What's new? Log in Free sign up

Filing search / Innovation Pharmaceuticals Inc. / "Expert"

Search information

Innovation Pharmaceuticals Inc.

Companies

"Expert"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

30 results

Newest first Best match first

IPIX Innovation Pharmaceuticals Inc.

, the FDA will review the NDA and may hold a public hearing where an independent advisory committee of expert advisors considers key questions regarding … . In addition, Dr. Schechter is an expert consultant for Gerson Lehrman and Guidepoint Global regarding the business and technology of eye care and consults

28 Sep 23

9:00am

IPIX Innovation Pharmaceuticals Inc.

accepting the NDA for filing, the FDA will review the NDA and may hold a public hearing where an independent advisory committee of expert advisors … , and cataract surgery, and glaucoma. In addition, Dr. Schechter is an expert consultant for Gerson Lehrman and Guidepoint Global regarding the business

28 Sep 22

4:00pm

IPIX Innovation Pharmaceuticals Inc.

an independent advisory committee of expert advisors considers key questions regarding the drug. This advisory committee makes a recommendation to the FDA … , infection, the latest in corneal, refractive, and cataract surgery, and glaucoma. In addition, Dr. Schechter is an expert consultant for Gerson Lehrman

27 Sep 21

4:16pm

IPIX Innovation Pharmaceuticals Inc.

Entry into a Material Definitive Agreement

not thereby admit that we are an “expert” within the meaning of the Securities Act of 1933, as amended. Very truly yours, /s/ Hogan Lovells US LLP HOGAN LOVELLS US LLP

IPIX Innovation Pharmaceuticals Inc.

will review the NDA and may hold a public hearing where an independent advisory committee of expert advisors considers key questions regarding … , and glaucoma. In addition, Dr. Schechter is an expert consultant for Gerson Lehrman regarding the business and technology of eye care and consults

14 Sep 20

4:50pm

Shelf registration

10 Jul 20

5:08pm

Prospectus update (post-effective amendment)

q4ro47rv2laduelm

30 Sep 19

4:37pm

Quarterly report

10 May 19

5:16pm

Innovation Pharmaceuticals Secures Up to $10 Million in Additional Financing to Advance Clinical Pipeline

11 Sep 18

12:00am

11 Sep 17

12:00am

5ka2bizu wci6p0dbz

11 Sep 17

12:00am

dl7hs4tq0a r32g

Annual report (amended)

28 Oct 16

12:00am

unofhzg5i1k7s wb50f0

13 Sep 16

12:00am

yb29ls6pg jfp9th

Quarterly report

9 May 16

12:00am

46tki4p5 fl8ku84as

11 Sep 15

12:00am

Quarterly report

11 May 15

12:00am

15 Sep 14

12:00am

30 Sep 13

12:00am

Prev
1
2
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.